欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
DK/H/3036/001
药品名称
Fluticasonpropionat "Teva"
活性成分
Fluticasone 50.0 µg
剂型
Nasal spray*
上市许可持有人
Teva B.V. Swensweg 5 2031 GA Haarlem Holland
参考成员国 - 产品名称
Denmark (DK)
互认成员国 - 产品名称
Norway (NO)
Flutikason Teva
United Kingdom (Northern Ireland) (XI)
Germany (DE)
Ireland (IE)
Spain (ES)
Portugal (PT)
Finland (FI)
Poland (PL)
Hungary (HU)
Czech Republic (CZ)
Slovak Republic (SK)
许可日期
2008/04/05
最近更新日期
2025/11/28
药物ATC编码
R01AD08 fluticasone
申请类型
TypeLevel1:
TypeLevel2:
TypeLevel3:
TypeLevel4:
TypeLevel5:
附件文件下载
Final PL
|
fluticasone_dk_h_3036_001_pil_23_09_24
Date of last change:2024/11/08
Final Labelling
|
fluticasone_dk_h_3036_001_oup_12_02_24
Date of last change:2024/11/08
Final Product Information
|
fluticasone_dk_h_3036_001_imp_30_09_24_2
Date of last change:2024/11/08
Final SPC
|
Fluticasone_DK_H_3036_001_SmPC_konsolidated_clean
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase